Global Oxcarbazepine Market Growth 2023-2028

Report ID: 1289858 | Published Date: Jan 2025 | No. of Page: 127 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Oxcarbazepine Annual Sales 2017-2028
        2.1.2 World Current & Future Analysis for Oxcarbazepine by Geographic Region, 2017, 2022 & 2028
        2.1.3 World Current & Future Analysis for Oxcarbazepine by Country/Region, 2017, 2022 & 2028
    2.2 Oxcarbazepine Segment by Type
        2.2.1 Tablets (150mg, 300mg, 600mg)
        2.2.2 Oral Suspension
    2.3 Oxcarbazepine Sales by Type
        2.3.1 Global Oxcarbazepine Sales Market Share by Type (2017-2022)
        2.3.2 Global Oxcarbazepine Revenue and Market Share by Type (2017-2022)
        2.3.3 Global Oxcarbazepine Sale Price by Type (2017-2022)
    2.4 Oxcarbazepine Segment by Application
        2.4.1 Pediatric Use (Aged 2-4 years, 4-16 years)
        2.4.2 Adult Use
    2.5 Oxcarbazepine Sales by Application
        2.5.1 Global Oxcarbazepine Sale Market Share by Application (2017-2022)
        2.5.2 Global Oxcarbazepine Revenue and Market Share by Application (2017-2022)
        2.5.3 Global Oxcarbazepine Sale Price by Application (2017-2022)
3 Global Oxcarbazepine by Company
    3.1 Global Oxcarbazepine Breakdown Data by Company
        3.1.1 Global Oxcarbazepine Annual Sales by Company (2020-2022)
        3.1.2 Global Oxcarbazepine Sales Market Share by Company (2020-2022)
    3.2 Global Oxcarbazepine Annual Revenue by Company (2020-2022)
        3.2.1 Global Oxcarbazepine Revenue by Company (2020-2022)
        3.2.2 Global Oxcarbazepine Revenue Market Share by Company (2020-2022)
    3.3 Global Oxcarbazepine Sale Price by Company
    3.4 Key Manufacturers Oxcarbazepine Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Oxcarbazepine Product Location Distribution
        3.4.2 Players Oxcarbazepine Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Oxcarbazepine by Geographic Region
    4.1 World Historic Oxcarbazepine Market Size by Geographic Region (2017-2022)
        4.1.1 Global Oxcarbazepine Annual Sales by Geographic Region (2017-2022)
        4.1.2 Global Oxcarbazepine Annual Revenue by Geographic Region
    4.2 World Historic Oxcarbazepine Market Size by Country/Region (2017-2022)
        4.2.1 Global Oxcarbazepine Annual Sales by Country/Region (2017-2022)
        4.2.2 Global Oxcarbazepine Annual Revenue by Country/Region
    4.3 Americas Oxcarbazepine Sales Growth
    4.4 APAC Oxcarbazepine Sales Growth
    4.5 Europe Oxcarbazepine Sales Growth
    4.6 Middle East & Africa Oxcarbazepine Sales Growth
5 Americas
    5.1 Americas Oxcarbazepine Sales by Country
        5.1.1 Americas Oxcarbazepine Sales by Country (2017-2022)
        5.1.2 Americas Oxcarbazepine Revenue by Country (2017-2022)
    5.2 Americas Oxcarbazepine Sales by Type
    5.3 Americas Oxcarbazepine Sales by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Oxcarbazepine Sales by Region
        6.1.1 APAC Oxcarbazepine Sales by Region (2017-2022)
        6.1.2 APAC Oxcarbazepine Revenue by Region (2017-2022)
    6.2 APAC Oxcarbazepine Sales by Type
    6.3 APAC Oxcarbazepine Sales by Application
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan
7 Europe
    7.1 Europe Oxcarbazepine by Country
        7.1.1 Europe Oxcarbazepine Sales by Country (2017-2022)
        7.1.2 Europe Oxcarbazepine Revenue by Country (2017-2022)
    7.2 Europe Oxcarbazepine Sales by Type
    7.3 Europe Oxcarbazepine Sales by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Oxcarbazepine by Country
        8.1.1 Middle East & Africa Oxcarbazepine Sales by Country (2017-2022)
        8.1.2 Middle East & Africa Oxcarbazepine Revenue by Country (2017-2022)
    8.2 Middle East & Africa Oxcarbazepine Sales by Type
    8.3 Middle East & Africa Oxcarbazepine Sales by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Oxcarbazepine
    10.3 Manufacturing Process Analysis of Oxcarbazepine
    10.4 Industry Chain Structure of Oxcarbazepine
11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Oxcarbazepine Distributors
    11.3 Oxcarbazepine Customer
12 World Forecast Review for Oxcarbazepine by Geographic Region
    12.1 Global Oxcarbazepine Market Size Forecast by Region
        12.1.1 Global Oxcarbazepine Forecast by Region (2023-2028)
        12.1.2 Global Oxcarbazepine Annual Revenue Forecast by Region (2023-2028)
    12.2 Americas Forecast by Country
    12.3 APAC Forecast by Region
    12.4 Europe Forecast by Country
    12.5 Middle East & Africa Forecast by Country
    12.6 Global Oxcarbazepine Forecast by Type
    12.7 Global Oxcarbazepine Forecast by Application
13 Key Players Analysis
    13.1 Novartis (Trileptal)
        13.1.1 Novartis (Trileptal) Company Information
        13.1.2 Novartis (Trileptal) Oxcarbazepine Product Offered
        13.1.3 Novartis (Trileptal) Oxcarbazepine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.1.4 Novartis (Trileptal) Main Business Overview
        13.1.5 Novartis (Trileptal) Latest Developments
    13.2 Supernus Pharmaceuticals (Oxtellar XR)
        13.2.1 Supernus Pharmaceuticals (Oxtellar XR) Company Information
        13.2.2 Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Product Offered
        13.2.3 Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.2.4 Supernus Pharmaceuticals (Oxtellar XR) Main Business Overview
        13.2.5 Supernus Pharmaceuticals (Oxtellar XR) Latest Developments
    13.3 Sun Pharm
        13.3.1 Sun Pharm Company Information
        13.3.2 Sun Pharm Oxcarbazepine Product Offered
        13.3.3 Sun Pharm Oxcarbazepine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.3.4 Sun Pharm Main Business Overview
        13.3.5 Sun Pharm Latest Developments
    13.4 Ranbaxy Pharmaceuticals
        13.4.1 Ranbaxy Pharmaceuticals Company Information
        13.4.2 Ranbaxy Pharmaceuticals Oxcarbazepine Product Offered
        13.4.3 Ranbaxy Pharmaceuticals Oxcarbazepine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.4.4 Ranbaxy Pharmaceuticals Main Business Overview
        13.4.5 Ranbaxy Pharmaceuticals Latest Developments
    13.5 Jubilant Generics
        13.5.1 Jubilant Generics Company Information
        13.5.2 Jubilant Generics Oxcarbazepine Product Offered
        13.5.3 Jubilant Generics Oxcarbazepine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.5.4 Jubilant Generics Main Business Overview
        13.5.5 Jubilant Generics Latest Developments
    13.6 Taro Pharmaceuticals
        13.6.1 Taro Pharmaceuticals Company Information
        13.6.2 Taro Pharmaceuticals Oxcarbazepine Product Offered
        13.6.3 Taro Pharmaceuticals Oxcarbazepine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.6.4 Taro Pharmaceuticals Main Business Overview
        13.6.5 Taro Pharmaceuticals Latest Developments
    13.7 Mylan
        13.7.1 Mylan Company Information
        13.7.2 Mylan Oxcarbazepine Product Offered
        13.7.3 Mylan Oxcarbazepine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.7.4 Mylan Main Business Overview
        13.7.5 Mylan Latest Developments
    13.8 Stada Group
        13.8.1 Stada Group Company Information
        13.8.2 Stada Group Oxcarbazepine Product Offered
        13.8.3 Stada Group Oxcarbazepine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.8.4 Stada Group Main Business Overview
        13.8.5 Stada Group Latest Developments
    13.9 Glenmark Pharmaceuticals
        13.9.1 Glenmark Pharmaceuticals Company Information
        13.9.2 Glenmark Pharmaceuticals Oxcarbazepine Product Offered
        13.9.3 Glenmark Pharmaceuticals Oxcarbazepine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.9.4 Glenmark Pharmaceuticals Main Business Overview
        13.9.5 Glenmark Pharmaceuticals Latest Developments
    13.10 ANI Pharmaceuticals
        13.10.1 ANI Pharmaceuticals Company Information
        13.10.2 ANI Pharmaceuticals Oxcarbazepine Product Offered
        13.10.3 ANI Pharmaceuticals Oxcarbazepine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.10.4 ANI Pharmaceuticals Main Business Overview
        13.10.5 ANI Pharmaceuticals Latest Developments
    13.11 Teva Pharmaceutical
        13.11.1 Teva Pharmaceutical Company Information
        13.11.2 Teva Pharmaceutical Oxcarbazepine Product Offered
        13.11.3 Teva Pharmaceutical Oxcarbazepine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.11.4 Teva Pharmaceutical Main Business Overview
        13.11.5 Teva Pharmaceutical Latest Developments
    13.12 Roxane Laboratories
        13.12.1 Roxane Laboratories Company Information
        13.12.2 Roxane Laboratories Oxcarbazepine Product Offered
        13.12.3 Roxane Laboratories Oxcarbazepine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.12.4 Roxane Laboratories Main Business Overview
        13.12.5 Roxane Laboratories Latest Developments
    13.13 Nobelpharma
        13.13.1 Nobelpharma Company Information
        13.13.2 Nobelpharma Oxcarbazepine Product Offered
        13.13.3 Nobelpharma Oxcarbazepine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.13.4 Nobelpharma Main Business Overview
        13.13.5 Nobelpharma Latest Developments
    13.14 Apotex
        13.14.1 Apotex Company Information
        13.14.2 Apotex Oxcarbazepine Product Offered
        13.14.3 Apotex Oxcarbazepine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.14.4 Apotex Main Business Overview
        13.14.5 Apotex Latest Developments
    13.15 Nexgen pharma
        13.15.1 Nexgen pharma Company Information
        13.15.2 Nexgen pharma Oxcarbazepine Product Offered
        13.15.3 Nexgen pharma Oxcarbazepine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.15.4 Nexgen pharma Main Business Overview
        13.15.5 Nexgen pharma Latest Developments
    13.16 Amneal Pharmaceuticals
        13.16.1 Amneal Pharmaceuticals Company Information
        13.16.2 Amneal Pharmaceuticals Oxcarbazepine Product Offered
        13.16.3 Amneal Pharmaceuticals Oxcarbazepine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.16.4 Amneal Pharmaceuticals Main Business Overview
        13.16.5 Amneal Pharmaceuticals Latest Developments
    13.17 Hikma Pharmaceuticals
        13.17.1 Hikma Pharmaceuticals Company Information
        13.17.2 Hikma Pharmaceuticals Oxcarbazepine Product Offered
        13.17.3 Hikma Pharmaceuticals Oxcarbazepine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.17.4 Hikma Pharmaceuticals Main Business Overview
        13.17.5 Hikma Pharmaceuticals Latest Developments
    13.18 Jamp Pharma
        13.18.1 Jamp Pharma Company Information
        13.18.2 Jamp Pharma Oxcarbazepine Product Offered
        13.18.3 Jamp Pharma Oxcarbazepine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.18.4 Jamp Pharma Main Business Overview
        13.18.5 Jamp Pharma Latest Developments
    13.19 Neuraxpharm
        13.19.1 Neuraxpharm Company Information
        13.19.2 Neuraxpharm Oxcarbazepine Product Offered
        13.19.3 Neuraxpharm Oxcarbazepine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.19.4 Neuraxpharm Main Business Overview
        13.19.5 Neuraxpharm Latest Developments
    13.20 Orion Corporation
        13.20.1 Orion Corporation Company Information
        13.20.2 Orion Corporation Oxcarbazepine Product Offered
        13.20.3 Orion Corporation Oxcarbazepine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.20.4 Orion Corporation Main Business Overview
        13.20.5 Orion Corporation Latest Developments
    13.21 Sihuan Pharm
        13.21.1 Sihuan Pharm Company Information
        13.21.2 Sihuan Pharm Oxcarbazepine Product Offered
        13.21.3 Sihuan Pharm Oxcarbazepine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.21.4 Sihuan Pharm Main Business Overview
        13.21.5 Sihuan Pharm Latest Developments
    13.22 Humanwell Healthcare
        13.22.1 Humanwell Healthcare Company Information
        13.22.2 Humanwell Healthcare Oxcarbazepine Product Offered
        13.22.3 Humanwell Healthcare Oxcarbazepine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.22.4 Humanwell Healthcare Main Business Overview
        13.22.5 Humanwell Healthcare Latest Developments
    13.23 Huikang Pharmaceutical
        13.23.1 Huikang Pharmaceutical Company Information
        13.23.2 Huikang Pharmaceutical Oxcarbazepine Product Offered
        13.23.3 Huikang Pharmaceutical Oxcarbazepine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.23.4 Huikang Pharmaceutical Main Business Overview
        13.23.5 Huikang Pharmaceutical Latest Developments
14 Research Findings and Conclusion
List of Tables
    Table 1. Oxcarbazepine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
    Table 2. Oxcarbazepine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
    Table 3. Major Players of Tablets (150mg, 300mg, 600mg)
    Table 4. Major Players of Oral Suspension
    Table 5. Global Oxcarbazepine Sales by Type (2017-2022) & (M Unit)
    Table 6. Global Oxcarbazepine Sales Market Share by Type (2017-2022)
    Table 7. Global Oxcarbazepine Revenue by Type (2017-2022) & ($ million)
    Table 8. Global Oxcarbazepine Revenue Market Share by Type (2017-2022)
    Table 9. Global Oxcarbazepine Sale Price by Type (2017-2022) & (USD/Unit)
    Table 10. Global Oxcarbazepine Sales by Application (2017-2022) & (M Unit)
    Table 11. Global Oxcarbazepine Sales Market Share by Application (2017-2022)
    Table 12. Global Oxcarbazepine Revenue by Application (2017-2022)
    Table 13. Global Oxcarbazepine Revenue Market Share by Application (2017-2022)
    Table 14. Global Oxcarbazepine Sale Price by Application (2017-2022) & (USD/Unit)
    Table 15. Global Oxcarbazepine Sales by Company (2020-2022) & (M Unit)
    Table 16. Global Oxcarbazepine Sales Market Share by Company (2020-2022)
    Table 17. Global Oxcarbazepine Revenue by Company (2020-2022) ($ Millions)
    Table 18. Global Oxcarbazepine Revenue Market Share by Company (2020-2022)
    Table 19. Global Oxcarbazepine Sale Price by Company (2020-2022) & (USD/Unit)
    Table 20. Key Manufacturers Oxcarbazepine Producing Area Distribution and Sales Area
    Table 21. Players Oxcarbazepine Products Offered
    Table 22. Oxcarbazepine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 23. New Products and Potential Entrants
    Table 24. Mergers & Acquisitions, Expansion
    Table 25. Global Oxcarbazepine Sales by Geographic Region (2017-2022) & (M Unit)
    Table 26. Global Oxcarbazepine Sales Market Share Geographic Region (2017-2022)
    Table 27. Global Oxcarbazepine Revenue by Geographic Region (2017-2022) & ($ millions)
    Table 28. Global Oxcarbazepine Revenue Market Share by Geographic Region (2017-2022)
    Table 29. Global Oxcarbazepine Sales by Country/Region (2017-2022) & (M Unit)
    Table 30. Global Oxcarbazepine Sales Market Share by Country/Region (2017-2022)
    Table 31. Global Oxcarbazepine Revenue by Country/Region (2017-2022) & ($ millions)
    Table 32. Global Oxcarbazepine Revenue Market Share by Country/Region (2017-2022)
    Table 33. Americas Oxcarbazepine Sales by Country (2017-2022) & (M Unit)
    Table 34. Americas Oxcarbazepine Sales Market Share by Country (2017-2022)
    Table 35. Americas Oxcarbazepine Revenue by Country (2017-2022) & ($ Millions)
    Table 36. Americas Oxcarbazepine Revenue Market Share by Country (2017-2022)
    Table 37. Americas Oxcarbazepine Sales by Type (2017-2022) & (M Unit)
    Table 38. Americas Oxcarbazepine Sales Market Share by Type (2017-2022)
    Table 39. Americas Oxcarbazepine Sales by Application (2017-2022) & (M Unit)
    Table 40. Americas Oxcarbazepine Sales Market Share by Application (2017-2022)
    Table 41. APAC Oxcarbazepine Sales by Region (2017-2022) & (M Unit)
    Table 42. APAC Oxcarbazepine Sales Market Share by Region (2017-2022)
    Table 43. APAC Oxcarbazepine Revenue by Region (2017-2022) & ($ Millions)
    Table 44. APAC Oxcarbazepine Revenue Market Share by Region (2017-2022)
    Table 45. APAC Oxcarbazepine Sales by Type (2017-2022) & (M Unit)
    Table 46. APAC Oxcarbazepine Sales Market Share by Type (2017-2022)
    Table 47. APAC Oxcarbazepine Sales by Application (2017-2022) & (M Unit)
    Table 48. APAC Oxcarbazepine Sales Market Share by Application (2017-2022)
    Table 49. Europe Oxcarbazepine Sales by Country (2017-2022) & (M Unit)
    Table 50. Europe Oxcarbazepine Sales Market Share by Country (2017-2022)
    Table 51. Europe Oxcarbazepine Revenue by Country (2017-2022) & ($ Millions)
    Table 52. Europe Oxcarbazepine Revenue Market Share by Country (2017-2022)
    Table 53. Europe Oxcarbazepine Sales by Type (2017-2022) & (M Unit)
    Table 54. Europe Oxcarbazepine Sales Market Share by Type (2017-2022)
    Table 55. Europe Oxcarbazepine Sales by Application (2017-2022) & (M Unit)
    Table 56. Europe Oxcarbazepine Sales Market Share by Application (2017-2022)
    Table 57. Middle East & Africa Oxcarbazepine Sales by Country (2017-2022) & (M Unit)
    Table 58. Middle East & Africa Oxcarbazepine Sales Market Share by Country (2017-2022)
    Table 59. Middle East & Africa Oxcarbazepine Revenue by Country (2017-2022) & ($ Millions)
    Table 60. Middle East & Africa Oxcarbazepine Revenue Market Share by Country (2017-2022)
    Table 61. Middle East & Africa Oxcarbazepine Sales by Type (2017-2022) & (M Unit)
    Table 62. Middle East & Africa Oxcarbazepine Sales Market Share by Type (2017-2022)
    Table 63. Middle East & Africa Oxcarbazepine Sales by Application (2017-2022) & (M Unit)
    Table 64. Middle East & Africa Oxcarbazepine Sales Market Share by Application (2017-2022)
    Table 65. Key Market Drivers & Growth Opportunities of Oxcarbazepine
    Table 66. Key Market Challenges & Risks of Oxcarbazepine
    Table 67. Key Industry Trends of Oxcarbazepine
    Table 68. Oxcarbazepine Raw Material
    Table 69. Key Suppliers of Raw Materials
    Table 70. Oxcarbazepine Distributors List
    Table 71. Oxcarbazepine Customer List
    Table 72. Global Oxcarbazepine Sales Forecast by Region (2023-2028) & (M Unit)
    Table 73. Global Oxcarbazepine Sales Market Forecast by Region
    Table 74. Global Oxcarbazepine Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 75. Global Oxcarbazepine Revenue Market Share Forecast by Region (2023-2028)
    Table 76. Americas Oxcarbazepine Sales Forecast by Country (2023-2028) & (M Unit)
    Table 77. Americas Oxcarbazepine Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 78. APAC Oxcarbazepine Sales Forecast by Region (2023-2028) & (M Unit)
    Table 79. APAC Oxcarbazepine Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 80. Europe Oxcarbazepine Sales Forecast by Country (2023-2028) & (M Unit)
    Table 81. Europe Oxcarbazepine Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 82. Middle East & Africa Oxcarbazepine Sales Forecast by Country (2023-2028) & (M Unit)
    Table 83. Middle East & Africa Oxcarbazepine Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 84. Global Oxcarbazepine Sales Forecast by Type (2023-2028) & (M Unit)
    Table 85. Global Oxcarbazepine Sales Market Share Forecast by Type (2023-2028)
    Table 86. Global Oxcarbazepine Revenue Forecast by Type (2023-2028) & ($ Millions)
    Table 87. Global Oxcarbazepine Revenue Market Share Forecast by Type (2023-2028)
    Table 88. Global Oxcarbazepine Sales Forecast by Application (2023-2028) & (M Unit)
    Table 89. Global Oxcarbazepine Sales Market Share Forecast by Application (2023-2028)
    Table 90. Global Oxcarbazepine Revenue Forecast by Application (2023-2028) & ($ Millions)
    Table 91. Global Oxcarbazepine Revenue Market Share Forecast by Application (2023-2028)
    Table 92. Novartis (Trileptal) Basic Information, Oxcarbazepine Manufacturing Base, Sales Area and Its Competitors
    Table 93. Novartis (Trileptal) Oxcarbazepine Product Offered
    Table 94. Novartis (Trileptal) Oxcarbazepine Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 95. Novartis (Trileptal) Main Business
    Table 96. Novartis (Trileptal) Latest Developments
    Table 97. Supernus Pharmaceuticals (Oxtellar XR) Basic Information, Oxcarbazepine Manufacturing Base, Sales Area and Its Competitors
    Table 98. Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Product Offered
    Table 99. Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 100. Supernus Pharmaceuticals (Oxtellar XR) Main Business
    Table 101. Supernus Pharmaceuticals (Oxtellar XR) Latest Developments
    Table 102. Sun Pharm Basic Information, Oxcarbazepine Manufacturing Base, Sales Area and Its Competitors
    Table 103. Sun Pharm Oxcarbazepine Product Offered
    Table 104. Sun Pharm Oxcarbazepine Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 105. Sun Pharm Main Business
    Table 106. Sun Pharm Latest Developments
    Table 107. Ranbaxy Pharmaceuticals Basic Information, Oxcarbazepine Manufacturing Base, Sales Area and Its Competitors
    Table 108. Ranbaxy Pharmaceuticals Oxcarbazepine Product Offered
    Table 109. Ranbaxy Pharmaceuticals Oxcarbazepine Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 110. Ranbaxy Pharmaceuticals Main Business
    Table 111. Ranbaxy Pharmaceuticals Latest Developments
    Table 112. Jubilant Generics Basic Information, Oxcarbazepine Manufacturing Base, Sales Area and Its Competitors
    Table 113. Jubilant Generics Oxcarbazepine Product Offered
    Table 114. Jubilant Generics Oxcarbazepine Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 115. Jubilant Generics Main Business
    Table 116. Jubilant Generics Latest Developments
    Table 117. Taro Pharmaceuticals Basic Information, Oxcarbazepine Manufacturing Base, Sales Area and Its Competitors
    Table 118. Taro Pharmaceuticals Oxcarbazepine Product Offered
    Table 119. Taro Pharmaceuticals Oxcarbazepine Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 120. Taro Pharmaceuticals Main Business
    Table 121. Taro Pharmaceuticals Latest Developments
    Table 122. Mylan Basic Information, Oxcarbazepine Manufacturing Base, Sales Area and Its Competitors
    Table 123. Mylan Oxcarbazepine Product Offered
    Table 124. Mylan Oxcarbazepine Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 125. Mylan Main Business
    Table 126. Mylan Latest Developments
    Table 127. Stada Group Basic Information, Oxcarbazepine Manufacturing Base, Sales Area and Its Competitors
    Table 128. Stada Group Oxcarbazepine Product Offered
    Table 129. Stada Group Oxcarbazepine Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 130. Stada Group Main Business
    Table 131. Stada Group Latest Developments
    Table 132. Glenmark Pharmaceuticals Basic Information, Oxcarbazepine Manufacturing Base, Sales Area and Its Competitors
    Table 133. Glenmark Pharmaceuticals Oxcarbazepine Product Offered
    Table 134. Glenmark Pharmaceuticals Oxcarbazepine Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 135. Glenmark Pharmaceuticals Main Business
    Table 136. Glenmark Pharmaceuticals Latest Developments
    Table 137. ANI Pharmaceuticals Basic Information, Oxcarbazepine Manufacturing Base, Sales Area and Its Competitors
    Table 138. ANI Pharmaceuticals Oxcarbazepine Product Offered
    Table 139. ANI Pharmaceuticals Oxcarbazepine Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 140. ANI Pharmaceuticals Main Business
    Table 141. ANI Pharmaceuticals Latest Developments
    Table 142. Teva Pharmaceutical Basic Information, Oxcarbazepine Manufacturing Base, Sales Area and Its Competitors
    Table 143. Teva Pharmaceutical Oxcarbazepine Product Offered
    Table 144. Teva Pharmaceutical Oxcarbazepine Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 145. Teva Pharmaceutical Main Business
    Table 146. Teva Pharmaceutical Latest Developments
    Table 147. Roxane Laboratories Basic Information, Oxcarbazepine Manufacturing Base, Sales Area and Its Competitors
    Table 148. Roxane Laboratories Oxcarbazepine Product Offered
    Table 149. Roxane Laboratories Oxcarbazepine Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 150. Roxane Laboratories Main Business
    Table 151. Roxane Laboratories Latest Developments
    Table 152. Nobelpharma Basic Information, Oxcarbazepine Manufacturing Base, Sales Area and Its Competitors
    Table 153. Nobelpharma Oxcarbazepine Product Offered
    Table 154. Nobelpharma Oxcarbazepine Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 155. Nobelpharma Main Business
    Table 156. Nobelpharma Latest Developments
    Table 157. Apotex Basic Information, Oxcarbazepine Manufacturing Base, Sales Area and Its Competitors
    Table 158. Apotex Oxcarbazepine Product Offered
    Table 159. Apotex Oxcarbazepine Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 160. Apotex Main Business
    Table 161. Apotex Latest Developments
    Table 162. Nexgen pharma Basic Information, Oxcarbazepine Manufacturing Base, Sales Area and Its Competitors
    Table 163. Nexgen pharma Oxcarbazepine Product Offered
    Table 164. Nexgen pharma Oxcarbazepine Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 165. Nexgen pharma Main Business
    Table 166. Nexgen pharma Latest Developments
    Table 167. Amneal Pharmaceuticals Basic Information, Oxcarbazepine Manufacturing Base, Sales Area and Its Competitors
    Table 168. Amneal Pharmaceuticals Oxcarbazepine Product Offered
    Table 169. Amneal Pharmaceuticals Oxcarbazepine Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 170. Amneal Pharmaceuticals Main Business
    Table 171. Amneal Pharmaceuticals Latest Developments
    Table 172. Hikma Pharmaceuticals Basic Information, Oxcarbazepine Manufacturing Base, Sales Area and Its Competitors
    Table 173. Hikma Pharmaceuticals Oxcarbazepine Product Offered
    Table 174. Hikma Pharmaceuticals Oxcarbazepine Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 175. Hikma Pharmaceuticals Main Business
    Table 176. Hikma Pharmaceuticals Latest Developments
    Table 177. Jamp Pharma Basic Information, Oxcarbazepine Manufacturing Base, Sales Area and Its Competitors
    Table 178. Jamp Pharma Oxcarbazepine Product Offered
    Table 179. Jamp Pharma Oxcarbazepine Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 180. Jamp Pharma Main Business
    Table 181. Jamp Pharma Latest Developments
    Table 182. Neuraxpharm Basic Information, Oxcarbazepine Manufacturing Base, Sales Area and Its Competitors
    Table 183. Neuraxpharm Oxcarbazepine Product Offered
    Table 184. Neuraxpharm Oxcarbazepine Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 185. Neuraxpharm Main Business
    Table 186. Neuraxpharm Latest Developments
    Table 187. Orion Corporation Basic Information, Oxcarbazepine Manufacturing Base, Sales Area and Its Competitors
    Table 188. Orion Corporation Oxcarbazepine Product Offered
    Table 189. Orion Corporation Oxcarbazepine Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 190. Orion Corporation Main Business
    Table 191. Orion Corporation Latest Developments
    Table 192. Sihuan Pharm Basic Information, Oxcarbazepine Manufacturing Base, Sales Area and Its Competitors
    Table 193. Sihuan Pharm Oxcarbazepine Product Offered
    Table 194. Sihuan Pharm Oxcarbazepine Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 195. Sihuan Pharm Main Business
    Table 196. Sihuan Pharm Latest Developments
    Table 197. Humanwell Healthcare Basic Information, Oxcarbazepine Manufacturing Base, Sales Area and Its Competitors
    Table 198. Humanwell Healthcare Oxcarbazepine Product Offered
    Table 199. Humanwell Healthcare Oxcarbazepine Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 200. Humanwell Healthcare Main Business
    Table 201. Humanwell Healthcare Latest Developments
    Table 202. Huikang Pharmaceutical Basic Information, Oxcarbazepine Manufacturing Base, Sales Area and Its Competitors
    Table 203. Huikang Pharmaceutical Oxcarbazepine Product Offered
    Table 204. Huikang Pharmaceutical Oxcarbazepine Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 205. Huikang Pharmaceutical Main Business
    Table 206. Huikang Pharmaceutical Latest Developments
List of Figures
    Figure 1. Picture of Oxcarbazepine
    Figure 2. Oxcarbazepine Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Oxcarbazepine Sales Growth Rate 2017-2028 (M Unit)
    Figure 7. Global Oxcarbazepine Revenue Growth Rate 2017-2028 ($ Millions)
    Figure 8. Oxcarbazepine Sales by Region (2021 & 2028) & ($ millions)
    Figure 9. Product Picture of Tablets (150mg, 300mg, 600mg)
    Figure 10. Product Picture of Oral Suspension
    Figure 11. Global Oxcarbazepine Sales Market Share by Type in 2021
    Figure 12. Global Oxcarbazepine Revenue Market Share by Type (2017-2022)
    Figure 13. Oxcarbazepine Consumed in Pediatric Use (Aged 2-4 years, 4-16 years)
    Figure 14. Global Oxcarbazepine Market: Pediatric Use (Aged 2-4 years, 4-16 years) (2017-2022) & (M Unit)
    Figure 15. Oxcarbazepine Consumed in Adult Use
    Figure 16. Global Oxcarbazepine Market: Adult Use (2017-2022) & (M Unit)
    Figure 17. Global Oxcarbazepine Sales Market Share by Application (2017-2022)
    Figure 18. Global Oxcarbazepine Revenue Market Share by Application in 2021
    Figure 19. Oxcarbazepine Revenue Market by Company in 2021 ($ Million)
    Figure 20. Global Oxcarbazepine Revenue Market Share by Company in 2021
    Figure 21. Global Oxcarbazepine Sales Market Share by Geographic Region (2017-2022)
    Figure 22. Global Oxcarbazepine Revenue Market Share by Geographic Region in 2021
    Figure 23. Global Oxcarbazepine Sales Market Share by Region (2017-2022)
    Figure 24. Global Oxcarbazepine Revenue Market Share by Country/Region in 2021
    Figure 25. Americas Oxcarbazepine Sales 2017-2022 (M Unit)
    Figure 26. Americas Oxcarbazepine Revenue 2017-2022 ($ Millions)
    Figure 27. APAC Oxcarbazepine Sales 2017-2022 (M Unit)
    Figure 28. APAC Oxcarbazepine Revenue 2017-2022 ($ Millions)
    Figure 29. Europe Oxcarbazepine Sales 2017-2022 (M Unit)
    Figure 30. Europe Oxcarbazepine Revenue 2017-2022 ($ Millions)
    Figure 31. Middle East & Africa Oxcarbazepine Sales 2017-2022 (M Unit)
    Figure 32. Middle East & Africa Oxcarbazepine Revenue 2017-2022 ($ Millions)
    Figure 33. Americas Oxcarbazepine Sales Market Share by Country in 2021
    Figure 34. Americas Oxcarbazepine Revenue Market Share by Country in 2021
    Figure 35. United States Oxcarbazepine Revenue Growth 2017-2022 ($ Millions)
    Figure 36. Canada Oxcarbazepine Revenue Growth 2017-2022 ($ Millions)
    Figure 37. Mexico Oxcarbazepine Revenue Growth 2017-2022 ($ Millions)
    Figure 38. Brazil Oxcarbazepine Revenue Growth 2017-2022 ($ Millions)
    Figure 39. APAC Oxcarbazepine Sales Market Share by Region in 2021
    Figure 40. APAC Oxcarbazepine Revenue Market Share by Regions in 2021
    Figure 41. China Oxcarbazepine Revenue Growth 2017-2022 ($ Millions)
    Figure 42. Japan Oxcarbazepine Revenue Growth 2017-2022 ($ Millions)
    Figure 43. South Korea Oxcarbazepine Revenue Growth 2017-2022 ($ Millions)
    Figure 44. Southeast Asia Oxcarbazepine Revenue Growth 2017-2022 ($ Millions)
    Figure 45. India Oxcarbazepine Revenue Growth 2017-2022 ($ Millions)
    Figure 46. Australia Oxcarbazepine Revenue Growth 2017-2022 ($ Millions)
    Figure 47. Europe Oxcarbazepine Sales Market Share by Country in 2021
    Figure 48. Europe Oxcarbazepine Revenue Market Share by Country in 2021
    Figure 49. Germany Oxcarbazepine Revenue Growth 2017-2022 ($ Millions)
    Figure 50. France Oxcarbazepine Revenue Growth 2017-2022 ($ Millions)
    Figure 51. UK Oxcarbazepine Revenue Growth 2017-2022 ($ Millions)
    Figure 52. Italy Oxcarbazepine Revenue Growth 2017-2022 ($ Millions)
    Figure 53. Russia Oxcarbazepine Revenue Growth 2017-2022 ($ Millions)
    Figure 54. Middle East & Africa Oxcarbazepine Sales Market Share by Country in 2021
    Figure 55. Middle East & Africa Oxcarbazepine Revenue Market Share by Country in 2021
    Figure 56. Egypt Oxcarbazepine Revenue Growth 2017-2022 ($ Millions)
    Figure 57. South Africa Oxcarbazepine Revenue Growth 2017-2022 ($ Millions)
    Figure 58. Israel Oxcarbazepine Revenue Growth 2017-2022 ($ Millions)
    Figure 59. Turkey Oxcarbazepine Revenue Growth 2017-2022 ($ Millions)
    Figure 60. GCC Country Oxcarbazepine Revenue Growth 2017-2022 ($ Millions)
    Figure 61. Manufacturing Cost Structure Analysis of Oxcarbazepine in 2021
    Figure 62. Manufacturing Process Analysis of Oxcarbazepine
    Figure 63. Industry Chain Structure of Oxcarbazepine
    Figure 64. Channels of Distribution
    Figure 65. Distributors Profiles
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Oxcarbazepine Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Oxcarbazepine Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Oxcarbazepine Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports